Company filings profile · CIK 0001232524
Jazz Pharmaceuticals Plc — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Jazz Pharmaceuticals Plc (JAZZ): 63 filings in the last 90 days vs 34 in the prior 90 (filing-velocity rising ↑ · 1.85×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 10, 2026. Source-linked, daily-refreshed.
Material 8-K events — Jazz Pharmaceuticals Plc
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 9, 2026 | Departure/Election of Directors or Officers | ↗ |
| Sep 23, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | Regulation FD Disclosure | ↗ |
| Aug 31, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
Watch Jazz Pharmaceuticals Plc automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 9, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Oct 8, 2026 | 144 | ↗ | |
| Oct 7, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Oct 6, 2026 | 144 | ↗ | |
| Oct 5, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Oct 1, 2026 | 144 | ↗ | |
| Sep 23, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | 8-K | Regulation FD Disclosure | ↗ |
| Sep 14, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 10, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 10, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 10, 2026 | 144 | ↗ | |
| Sep 8, 2026 | 144 | ↗ | |
| Sep 8, 2026 | 144 | ↗ | |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 2, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Sep 1, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 4 | PRIMARY DOCUMENT | ↗ |
| Aug 31, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 31, 2026 | 144 | ↗ | |
| Aug 27, 2026 | 144 | ↗ |